Insmed Incorporated
DE ˙ DB ˙ US4576693075
88,45 € ↑0,31 (0,35%)
2026-06-04
AKTIENPREIS
SecurityDE:IM8N / Insmed Incorporated
InstitutionBellevue Group AG
Latest Disclosed Ownership10,034 shares
Latest Disclosed Value $ 1,640,760
Bellevue Group AG reports 27.89% decrease in ownership of IM8N / Insmed Incorporated

On May 14, 2026 - Bellevue Group AG filed a 13F-HR form disclosing ownership of 10,034 shares of Insmed Incorporated (DE:IM8N) valued at $1,344,556 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 13,915 shares of Insmed Incorporated. This represents a change in shares of -27.89% during the quarter. The current value of the position is $887,507 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F INSMED COM PAR $.01 457669307 10,034 -3,881 -27.89 1,641 -32.26 0.0390
2026-02-17 2025-12-31 13F INSMED COM PAR $.01 457669307 13,915 -6,336 -31.29 2,422 -16.98 0.0459
2025-11-14 2025-09-30 13F INSMED COM PAR $.01 457669307 20,251 -61,146 -75.12 2,916 -64.40 0.0606
2025-08-14 2025-06-30 13F INSMED COM PAR $.01 457669307 81,397 -69,153 -45.93 8,192 -28.68 0.1805
2025-05-14 2025-03-31 13F INSMED COM PAR $.01 457669307 150,550 -107,933 -41.76 11,485 -35.64 0.2574
2025-02-14 2024-12-31 13F INSMED COM PAR $.01 457669307 258,483 -266,951 -50.81 17,846 -53.48 0.3435
2024-11-14 2024-09-30 13F INSMED COM PAR $.01 457669307 525,434 -496,266 -48.57 38,357 -43.97 0.6214
2024-08-14 2024-06-30 13F INSMED COM PAR $.01 457669307 1,021,700 -1,120,143 -52.30 68,454 17.80 1.1123
2024-05-15 2024-03-31 13F INSMED COM PAR $.01 457669307 2,141,843 -149,115 -6.51 58,108 -18.15 0.8862
2024-02-14 2023-12-31 13F INSMED COM PAR $.01 457669307 2,290,958 -871,777 -27.56 70,997 -11.10 1.0860
2023-11-14 2023-09-30 13F INSMED COM PAR $.01 457669307 3,162,735 -138,176 -4.19 79,859 14.66 1.2866
2023-08-14 2023-06-30 13F INSMED COM PAR $.01 457669307 3,300,911 7,809 0.24 69,649 24.05 0.9935
2023-05-15 2023-03-31 13F INSMED COM PAR $.01 457669307 3,293,102 15,895 0.49 56,147 -14.25 0.8148
2023-02-14 2022-12-31 13F INSMED COM PAR $.01 457669307 3,277,207 62,503 1.94 65,479 -5.44 0.8690
2022-11-14 2022-09-30 13F INSMED COM PAR $.01 457669307 3,214,704 -406,858 -11.23 69,245 -3.04 0.9938
2022-08-11 2022-06-30 13F INSMED COM PAR $.01 457669307 3,621,562 69,786 1.96 71,417 -14.44 1.0095
2022-05-13 2022-03-31 13F INSMED COM PAR $.01 457669307 3,551,776 30,915 0.88 83,467 -12.97 0.9692
2022-02-10 2021-12-31 13F INSMED COM PAR $.01 457669307 3,520,861 135,216 3.99 95,908 2.86 0.9886
2021-11-12 2021-09-30 13F INSMED COM PAR $.01 457669307 3,385,645 264,744 8.48 93,241 4.98 0.9462
2021-08-12 2021-06-30 13F INSMED COM PAR $.01 457669307 3,120,901 643,735 25.99 88,821 5.27 0.8670
2021-05-12 2021-03-31 13F INSMED COM PAR $.01 457669307 2,477,166 860,166 53.20 84,372 56.74 0.8927
2021-02-16 2020-12-31 13F INSMED COM PAR $.01 457669307 1,617,000 396,831 32.52 53,830 37.27 0.6165
2020-11-16 2020-09-30 13F INSMED COM PAR $.01 457669307 1,220,169 -236,005 -16.21 39,216 -2.21 0.5419
2020-08-13 2020-06-30 13F INSMED COM PAR $.01 457669307 1,456,174 -157,296 -9.75 40,103 55.05 0.5676
2020-05-14 2020-03-31 13F INSMED COM PAR $.01 457669307 1,613,470 29,910 1.89 25,864 -31.60 0.5016
2020-02-14 2019-12-31 13F INSMED COM PAR $.01 457669307 1,583,560 392,080 32.91 37,815 79.92 0.5995
2019-11-14 2019-09-30 13F INSMED COM PAR $.01 457669307 1,191,480 571,021 92.03 21,018 32.32 0.3909
2019-08-14 2019-06-30 13F INSMED COM PAR $.01 457669307 620,459 -38,975 -5.91 15,884 -17.14 0.2712
2019-05-15 2019-03-31 13F INSMED COM PAR $.01 457669307 659,434 -149,712 -18.50 19,170 80.58 1.0548
2019-02-12 2018-12-31 13F INSMED COM PAR $.01 457669307 809,146 242,845 42.88 10,616 -7.29 0.6980
2018-11-13 2018-09-30 13F INSMED COM PAR $.01 457669307 566,301 142,250 33.55 11,451 14.18 0.7264
2018-08-07 2018-06-30 13F INSMED COM PAR $.01 457669307 424,051 89,562 26.78 10,029 33.13 0.8550
2018-05-09 2018-03-31 13F INSMED COM PAR $.01 457669307 334,489 334,489 7,533 0.7463
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.